Avalanche Technology Joins the Xilinx Radiation Test Consortium with Enabling Boot Module Solutions for Space Community
FREMONT, Calif., Aug. 15, 2022 /PRNewswire-PRWeb/ -- Avalanche Technology, the leader in next generation MRAM technology, announced it is joining the Xilinx Radiation Test Consortium (XRTC), an organization comprised of industry, academia and government partners, pooling resources to characterize and mitigate radiation-induced effects in FPGAs, along with providing additional design enablement for improved utility in harsh environments such as outer space. One of this community's more substantive challenges in recent years has been lacking bootable memory solutions of sufficient density and radiation resilience, particularly for today's more demanding processors and FPGAs, such as Xilinx's Versal platform with a 1Gb image size. Avalanche's Gen 3 Space Grade MRAM-based solutions are being increasingly validated by the Defense Industrial Base (DIB) and Commercial Space ecosystem for their ability to realize the longstanding promise of MRAM as an ideal candidate for Unified Memory Architectures based on their uniquely high-reliability, endurance (10^16) and density (1Gb to 8Gb options available today), and low power (10mA per 1Gb).
- "As a new member of the XRTC, Avalanche continues to listen to the needs of the DIB and Commercial Space ecosystem, providing impactful solutions with commercial agility.
- "From all reports, Avalanche has the coolest part of the year, finally a good-density MRAM that is inherently radiation resilient and seems tailor-made for booting Versal devices.
- Since 2002, Xilinx Radiation Test Consortium (XRTC) partners have pooled resources through the XRTC to characterize and mitigate radiation-induced effects in FPGAs with the goal of boldly increasing their use in harsh radiation environments, esp.
- The Consortium brings together top experts from industry, government, and academia to test and characterize radiation effects and mitigation techniques for re-configurable FPGAs.